Published 04-25-05
Submitted by Bayer
MSMS is Bayer's award-winning, company-wide initiative that advances science literacy across the United States through hands-on, inquiry-based learning, employee volunteerism and public education. Over the years, it has introduced tens of thousands of students to National Science Education Standards-based inquiry learning, provided professional development for thousands of teachers and offered the expertise of its science volunteers to countless schools around the country for both formal and informal science education experiences.
"Ten years ago, Bayer Corporation declared its commitment to strengthening science education in the United States when we established Making Science Make Sense. In so doing, we formally launched a nationwide, grassroots science education outreach program built on a foundation created over 30 years by Bayer science volunteers," said Dr. Attila Molnar, Bayer Corporation president and CEO.
Dr. Molnar added the company plans to celebrate this milestone with the following series of projects and events that will take place through the end of the year:
Bayer Corporation, headquartered in Pittsburgh, is part of the worldwide Bayer Group, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. Bayer employs nearly 17,000 in North America with net North American sales of 8.4 billion euros in 2004. Bayer's three operating companies - Bayer HealthCare LLC, Bayer CropScience LP and Bayer MaterialScience LLC - improve people's lives through a broad range of essential products that help diagnose and treat diseases, protect crops and advance automobile safety and durability.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
More from Bayer